Emerging Markets outlook: Attention may turn towards lightly traded ultra-low-priced stocks and biotech-related stocks.

■ Emerging Markets outside of the investment radar. This week, Emerging Markets declined. During the same period, while the Nikkei average dropped by -1.95%, the Growth Market Index fell by -2.67% and the Growth Market 250 Index decreased by -3.09%, indicating that Emerging Markets were relatively weak. As attention turns to the central bank meetings in Japan and the US, reports of Nissan <7201> and Honda <7267> beginning discussions on a management integration have led to speculation surrounding Main Board auto stocks and Auto Parts suppliers, leaving Emerging Markets outside of active investment consideration.

Fisco JapanDec 21 12:56

The Tokyo Stock Exchange Growth Index continues to decline, with lackluster price movements ahead of the Japan and US central bank meetings.

Tokyo Stock Exchange Growth Market Index 814.89 -2.43 / Volume 0.2 billion 14.75 million shares / Trading value 145.5 billion yen Tokyo Stock Exchange Growth Market 250 Index 635.44 -2.83 / Volume 0.1 billion 5.09 million shares / Trading value 97.2 billion yen Today's growth market saw a continued decline in both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, with 187 rising stocks, 363 declining stocks, and 45 unchanged. Today's growth market showed a soft trend. On the previous day, October 16 in the USA.

Fisco JapanDec 17 15:55

OncoTherapy Science 1H Loss Y545.00M Vs Loss Y710.00M

Dow JonesNov 11 12:01

OncoTherapy Science: Confirmation letter

EDINETNov 11 08:25 · Announcements

OncoTherapy Science: Semi-annual report - 24th term (2024/04/01 - 2025/03/31)

EDINETNov 11 08:23 · Announcements

SoftBank, 25/3 upward revision operating profit 950 billion yen ← 900 billion yen.

SoftBank <9434> announced a revision to its forecast for the fiscal year ending March 2025. The revenue was revised upward from 6 trillion 200 billion yen to 6 trillion 350 billion yen, and the operating profit from 900 billion yen to 950 billion yen. The strong performance of its subsidiary PayPay, a major player in smart phone payments, as well as the recovery of the mobile business, contributed to this. Positive evaluations for Secom midterm <9735>, Kaken Pharmaceuticals midterm <4521>, Olympus midterm <7733>, Fukui silver revision <8362>, Tokyu midterm <9005>.

Fisco JapanNov 11 05:33